Locate Therapeutics is a regenerative medicine development company. Regenerative medicine holds the promise of transforming patient care. It has vast economic potential, estimated at up to $5Bn, and is challenging spiralling health care budgets with its curative approach to disease management. The sector has now started to gain real commercial traction and is set for exponential growth.
The company has been formed around the research interests of Professor Kevin Shakesheff (formerly of the Langer Labs at M.I.T.) who is Director of both the Wolfson Centre for Stem Cells, Tissue Engineering and Modeling (STEM) and the UK Regenerative Medicine Platform Hub in Acellular Technologies at the University of Nottingham, UK. Previous investments by Heraeus Medical GmbH and the Wellcome Trust have allowed Locate to create a robust pipeline of in-house products for orthopaedic applications and to establish a number of exciting partner programmes. The Company also has exclusive rights to future intellectual property generated by Prof. Shakesheff and his world leading regenerative medicine team.
For further information please email email@example.com or call +44 (0)115 784 0041.